Anidulafungin. CommentariesMURDOCH, David; PLOSKER, Greg L; STEINBACH, J et al.Drugs (Basel). 2004, Vol 64, Num 19, pp 2249-2260, issn 0012-6667, 12 p.Article

A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal CandidiasisVAZQUEZ, José A; SCHRANZ, Jennifer A; CLARK, Kay et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 3, pp 304-309, issn 1525-4135, 6 p.Article

Anidulafungin : A novel echinocandinVAZQUEZ, Jose A; SOBEL, Jack D.Clinical infectious diseases. 2006, Vol 43, Num 2, pp 215-222, issn 1058-4838, 8 p.Article

Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant RecipientsWINSTON, D. J; LIMAYE, A. P; PELLETIER, S et al.American journal of transplantation (Print). 2014, Vol 14, Num 12, pp 2758-2764, issn 1600-6135, 7 p.Article

Invasive candidiasis: update on current pharmacotherapy options and future perspectivesTRAGIANNIDIS, Athanasios; TSOULAS, Christos; KERL, Kornelius et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 11, pp 1515-1528, issn 1465-6566, 14 p.Article

Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic ApproachesBEYDA, Nicholas D; LEWIS, Russell E; GAREY, Kevin W et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 7-8, pp 1086-1096, issn 1060-0280, 11 p.Article

Characterization of Candida parapsilosis complex isolatesDE TORO, M; TORRES, M. J; MAITE, Ruiz et al.Clinical microbiology and infection. 2011, Vol 17, Num 3, pp 418-424, issn 1198-743X, 7 p.Article

Development of an HPLC Method for the Determination of Anidulafungin in Human Plasma and SalineSUTHERLAND, Christina A; NICOLAU, David P; KUTI, Joseph L et al.Journal of chromatographic science. 2011, Vol 49, Num 5, pp 397-400, issn 0021-9665, 4 p.Article

Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosisSMITH, Raymond P; BALTCH, Aldona; BOPP, Lawrence H et al.Diagnostic microbiology and infectious disease. 2011, Vol 71, Num 2, pp 131-138, issn 0732-8893, 8 p.Article

In Vitro Activity of Anidulafungin and Other Agents against Esophageal Candidiasis-Associated Isolates from a Phase 3 Clinical TrialPFALLER, M. A; HOLLIS, R; GOLDSTEIN, B. P et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 7, pp 2613-2614, issn 0095-1137, 2 p.Article

Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosisFALCONE, Marco; ACCARPIO, Fabio; VENDITTI, Mario et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 10, pp 2266-2267, issn 0305-7453, 2 p.Article

Clinical Experience of Anidulafungin for the Treatment of Patients with Documented CandidemiaFALCONE, M; RUSSO, A; DE ROSA, F. G et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 6, pp 397-401, issn 1120-009X, 5 p.Article

In Vitro and In Vivo Studies To Characterize the Clearance Mechanism and Potential Cytochrome P450 Interactions of AnidulafunginDAMLE, Bharat D; DOWELL, James A; WALSKY, Robert L et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 3, pp 1149-1156, issn 0066-4804, 8 p.Article

Anidulafungin, a New Echinocandin: Effectiveness and TolerabilityMENICHETTI, Francesco.Drugs (Basel). 2009, Vol 69, pp 95-97, issn 0012-6667, 3 p., SUP1Article

Anidulafungin in the treatment of patients with invasive candidiasisKETT, Daniel H; FERNANDO CUBILLOS, G.International journal of antimicrobial agents (Print). 2008, Vol 32, issn 0924-8579, s99-s102, SUP2Conference Paper

Propriétés pharmacocinétiques et pharmacodynamiques de l'anidulafungineDUPONT, Hervé.Réanimation (Paris. 2001). 2007, Vol 16, issn 1624-0693, S267-S272, SUP3Article

Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasisPFALLER, M. A; DIEKEMA, D. J; BOYKEN, L et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4795-4797, issn 0066-4804, 3 p.Article

Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafunginODABASI, Zekaver; PAETZNICK, Victor; GOLDSTEIN, Beth P et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 9, pp 3018-3020, issn 0066-4804, 3 p.Article

Anidulafungin versus Caspofungin in a Mouse Model of Candidiasis Caused by Anidulafungin-Susceptible Candida parapsilosis Isolates with Different Degrees of Caspofungin SusceptibilityDIMOPOULOU, Dimitra; HAMILOS, Georgios; TZARDI, Maria et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 229-236, issn 0066-4804, 8 p.Article

Population Pharmacokinetic-Pharmacodynamic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive AspergillosisPING LIU; MOULD, Diane R.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4727-4736, issn 0066-4804, 10 p.Article

Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening InfectionLIVERMORE, J. L; FELTON, T. W; ABBOTT, J et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 281-288, issn 0066-4804, 8 p.Article

Population Pharmacokinetic-Pharmacodynamic Analysis of Anidulafungin in Adult Patients with Fungal InfectionsPING LIU.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 466-474, issn 0066-4804, 9 p.Article

In Vitro Combination of Anidulafungin and Voriconazole against Intrinsically Azole-Susceptible and -Resistant Aspergillus sppPLANCHE, Virginie; DUCROZ, Sebastien; ALANIO, Alexandre et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 8, pp 4500-4503, issn 0066-4804, 4 p.Article

Novel Method for Evaluating In Vitro Activity of Anidulafungin in Combination with Amphotericin B or AzolesTEIXEIRA-SANTOS, R; ROCHA, R; MOREIRA-ROSARIO, A et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 8, pp 2748-2754, issn 0095-1137, 7 p.Article

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasisNEOH, Chin Fen; LIEW, Danny; SLAVIN, Monica et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 8, pp 1906-1915, issn 0305-7453, 10 p.Article